Jaroslaw Drozdz
0000-0002-0732-2104
575 papers found
Refreshing results…
Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction
Infective endocarditis in a 52-year-old male patient with vegetations of all four heart valves and extremely high cardiac operative risk
Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction— Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction Deliver Trial
A rare discovery in the left atrium: A high-grade sarcoma with cerebral metastasis
The prevalence and association of major ECG abnormalities with clinical characteristics and the outcomes of real-life heart failure patients — Heart Failure Registries of the Eu ropean Society of Cardiology
Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index
Masywna zatorowość płucna u 33-letniego mężczyzny ze słabymi czynnikami ryzyka do żylnej choroby zakrzepowo-zatorowej – postępowanie według wytycznych ESC
Hospitalization and interventional procedures in cardiology departments covering a region with 2.5 million inhabitants during the SARS-CoV-2 pandemic
Impact of the COVID-19 pandemic on the performance of selected cardiac electrotherapy and electrophysiology procedures
Expert opinion of the Heart Failure Working Group of the Polish Cardiac Society on the use of dapagliflozin in the treatment of heart failure with reduced ejection fraction
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF
Zaburzenia rytmu serca - migotanie przedsionków
C jak COVID-19 — powikłania układu sercowo-naczyniowego u młodego pacjenta
Ból w klatce piersiowej — czy zawsze jest tym, czym się wydaje?
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
Missing publications? Search for publications with a matching author name.